View in EDS

Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study.

Saved in:
Bibliographic Details
Title: Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study.
Authors: Singer MA; Medical Center Ophthalmology Associates, San Antonio, Texas; University of Texas Health Science Center, San Antonio, Texas. Electronic address: msinger11@me.com., Wykoff CC; Retina Consultants of Texas, Houston, Texas., Riemann CD; Cincinnati Eye Institute, Cincinnati, Ohio; Department of Ophthalmology, University of Cincinnati College of Medicine, Cincinnati, Ohio., Gonzalez VH; Valley Retina Institute, McAllen, Texas., Weng CY; Department of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston, Texas., Alkhatib K; ANI Pharmaceuticals, Inc., Baudette, Minnesota., Amarshi RA; ANI Pharmaceuticals, Inc., Baudette, Minnesota., Moody S; ANI Pharmaceuticals, Inc., Baudette, Minnesota., Pao M; ANI Pharmaceuticals, Inc., Baudette, Minnesota.
Source: Ophthalmology [Ophthalmology] 2026 Jul; Vol. 133 (7), pp. 837-851. Date of Electronic Publication: 2026 Mar 25.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase IV
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-4713 (Electronic) Linking ISSN: 01616420 NLM ISO Abbreviation: Ophthalmology Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41887289
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Singer+MA%22">Singer MA</searchLink>; Medical Center Ophthalmology Associates, San Antonio, Texas; University of Texas Health Science Center, San Antonio, Texas. Electronic address: msinger11@me.com.<br /><searchLink fieldCode="AU" term="%22Wykoff+CC%22">Wykoff CC</searchLink>; Retina Consultants of Texas, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Riemann+CD%22">Riemann CD</searchLink>; Cincinnati Eye Institute, Cincinnati, Ohio; Department of Ophthalmology, University of Cincinnati College of Medicine, Cincinnati, Ohio.<br /><searchLink fieldCode="AU" term="%22Gonzalez+VH%22">Gonzalez VH</searchLink>; Valley Retina Institute, McAllen, Texas.<br /><searchLink fieldCode="AU" term="%22Weng+CY%22">Weng CY</searchLink>; Department of Ophthalmology, Cullen Eye Institute, Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Alkhatib+K%22">Alkhatib K</searchLink>; ANI Pharmaceuticals, Inc., Baudette, Minnesota.<br /><searchLink fieldCode="AU" term="%22Amarshi+RA%22">Amarshi RA</searchLink>; ANI Pharmaceuticals, Inc., Baudette, Minnesota.<br /><searchLink fieldCode="AU" term="%22Moody+S%22">Moody S</searchLink>; ANI Pharmaceuticals, Inc., Baudette, Minnesota.<br /><searchLink fieldCode="AU" term="%22Pao+M%22">Pao M</searchLink>; ANI Pharmaceuticals, Inc., Baudette, Minnesota.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227802443%22">Ophthalmology</searchLink> [Ophthalmology] 2026 Jul; Vol. 133 (7), pp. 837-851. <i>Date of Electronic Publication: </i>2026 Mar 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Multicenter Study; Clinical Trial, Phase IV
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7802443 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1549-4713 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201616420%22">01616420 </searchLink><i>NLM ISO Abbreviation: </i>Ophthalmology <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41887289
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ophtha.2026.03.019
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 837
    Titles:
      – TitleFull: Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Singer MA
      – PersonEntity:
          Name:
            NameFull: Wykoff CC
      – PersonEntity:
          Name:
            NameFull: Riemann CD
      – PersonEntity:
          Name:
            NameFull: Gonzalez VH
      – PersonEntity:
          Name:
            NameFull: Weng CY
      – PersonEntity:
          Name:
            NameFull: Alkhatib K
      – PersonEntity:
          Name:
            NameFull: Amarshi RA
      – PersonEntity:
          Name:
            NameFull: Moody S
      – PersonEntity:
          Name:
            NameFull: Pao M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1549-4713
          Numbering:
            – Type: volume
              Value: 133
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Ophthalmology
              Type: main
ResultId 1